Current Advances of Molecular Biomarkers and Liquid Biopsies Techniques in Ovarian Cancer
This review summarizes advances in liquid biopsy technologies, focusing on circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).
We have 2 of 27 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
This review summarizes advances in liquid biopsy technologies, focusing on circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).
This comprehensive analysis examines the integrated dysregulation of core mitochondrial processes—bioenergetic metabolism, organelle dynamics, programmed cell death pathways, redox homeostasis, and selective autophagy—in driving RCC pathogenesis and establishes mitochondrial dysfunction as a central determinant of RCC...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.